Innospec (IOSP) Tops Q3 EPS by 14c

Innospec (NASDAQ: IOSP) reported Q3 EPS of $1.15, $0.14 better than the analyst estimate of $1.01. Revenue for the quarter came in at $376.1 million versus the consensus estimate of $346.15 million.

For earnings history and earnings-related data on Innospec (IOSP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c